Page 132 - Medicine and Surgery
P. 132

P1: FAW
         BLUK007-03  BLUK007-Kendall  May 25, 2005  17:29  Char Count= 0








                   128 Chapter 3: Respiratory system


                     acute exacerbations of asthma or COPD, pulmonary  Management
                     oedema, pneumonia, pulmonary embolus and fibros-  Acute or acute on chronic respiratory failure
                     ing alveolitis. Hyperventilation frequently leads to a  Treat any reversible underlying cause:
                     low pCO 2 .                                    Oversedation or opiate overdose by stopping or re-
                     Type II failure, sometimes called ‘ventilatory failure’,  versing sedation (e.g. flumazenil for benzodiazepines,

                     is due to alveolar hypoventilation such that the car-  naloxone for opiates).
                     bon dioxide produced by tissue metabolism cannot     Pulmonary oedema with diuretics.
                     be adequately removed and pCO 2 rises. If the failure     Asthma by bronchodilators and corticosteroids.
                     is chronic the patient with a type II respiratory fail-     Pneumonia with appropriate antibiotics.
                     ure will lose sensitivity to a raised carbon dioxide and     Pneumothorax or pleural effusion by aspiration or
                     thereforerelysolelyonhypoxicrespiratorydrive.Ifag-  drainage.
                     gressive oxygen therapy is initiated the level of oxygen     COPD with bronchodilators, corticosteroids and an-
                     will rise and the respiratory drive is diminished, lead-  tibiotics.
                     ingtofurtherdecreasedventilationwhichmaybefatal.  Controlled oxygen therapy:
                     The most common cause of type II respiratory failure     In patients who have a raised pCO 2 > 6kPa, oxygen
                     is chronic obstructive airway disease, other causes in-  therapy can potentially worsen the situation, because
                     clude any severe respiratory disease, failure of respi-  of the patient’s dependence on hypoxic drive. Con-
                     ratory effort, e.g. central drive depression, chest-wall  trolled 24–28% oxygen is given by Venturi mask and
                     disease such as deformity and neuromuscular disease  arterialbloodgasesarerepeatedtoensurethatthepO 2
                     such as myasthenia.                          is rising and the pCO 2 is not rising.
                                                                  In patients with acute hypoxaemic failure and a nor-

                                                                  mal or low pCO 2 , high-flow oxygen therapy can be
                   Clinical features                              used, but they must still be closely monitored with
                   Ina patient with a normal haemoglobin central cyanosis
                                                                  regular arterial blood gases to ensure that they are not
                   is visible when the pO 2 falls below 6.7 kPa. Hypercap-
                                                                  tiring and developing type II failure.
                   nia causes a flapping tremor of the outstretched hands, a
                                                                If pCO 2 continues to rise or pO 2 cannot be raised ade-
                   bounding pulse, vasodilation, increased agitation, then
                                                                quately with oxygen therapy then assisted ventilation is
                   confusion, drowsiness and coma. Other signs include
                                                                required, preferably before patients are completely ex-
                   the use of accessory muscles of respiration, tachypnoea,
                                                                hausted (see Table 3.17).
                   tachycardia, sweating and inability to speak in full sen-
                   tences.                                      Chronic respiratory failure
                                                                Long-term oxygen therapy (LTOT) and in some cases
                                                                non-invasive ventilation, is indicated for chronic respi-
                   Complications
                                                                ratory failure. LTOT is indicated in patients with COPD
                     Pulmonary hypertension due to hypoxic pulmonary

                                                                who haveapO 2 < 7.3 kPa when stable or a pO 2 > 7.3
                     vasoconstriction. With time the arteries undergo a
                                                                and <8kPa when stable with polycythaemia, nocturnal
                     proliferative change leading to irreversible pulmonary
                                                                hypoxaemia, peripheral oedema or pulmonary hyper-
                     circulationchanges.Thereisincreasedafterloadonthe
                                                                tension. 19 hours/day of oxygen 1–3 L/minute has been
                     right side of the heart leading to cor pulmonale.
                                                                showntoincreasesurvivalinpatientswithchronicbron-
                     Polycythaemia results from hypoxia, it causes an

                                                                chitis or emphysema and respiratory failure. Patients
                     increase in blood viscosity and predisposes to
                                                                must have stopped smoking (for safety reasons), and an
                     thrombosis.
                                                                oxygen concentrator needs to be installed in their home.
                   Investigations                               Prognosis
                   Blood gas monitoring is the most important initial in-  Fifty per cent of patients with severe chronic breathless-
                   vestigation to establish the type of failure and will dictate  ness die within 5 years, but in all stopping smoking is the
                   the mode of oxygen therapy.                  most beneficial therapy.
   127   128   129   130   131   132   133   134   135   136   137